You are here

Article Text

Article menu
Download PDFPDF
Letter
Treatment regimens in non-gonococcal urethritis
  1. Naomi Carter1,
  2. Paddy Horner2
  1. 1 University Hospitals Bristol Trust, Bristol, UK
  2. 2 Bristol Sexual Health Centre, University Hospitals Bristol Trust, Bristol, UK
  1. Correspondence to Dr Paddy Horner, Bristol Sexual Health Centre, University Hospitals Bristol Trust, Bristol BS2 0JD, UK; Paddy.Horner{at}bristol.ac.uk

https://doi.org/10.1136/sextrans-2014-051837

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A letter in response to: ‘Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study’ and ‘Empiric NSU treatment needs updating’.1 ,2

    The effect of suboptimal adherence to a 7-day 100 mg twice daily doxycycline regimen on treatment failure in men with non-gonococcal urethritis (NGU) was assessed by Khosropour et al.1 The authors conclude that suboptimal adherence to doxycycline, defined as missing one or more doses, is associated with microbiological failure in chlamydial NGU in men.1 We …

    View Full Text

    Footnotes

    • Contributors The authors contributed equally to this submission.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.